Related references
Note: Only part of the references are listed.PSA, stage, grade and prostate cancer specific mortality in Asian American patients relative to Caucasians according to the United States Census Bureau race definitions
Marina Deuker et al.
WORLD JOURNAL OF UROLOGY (2021)
Nutrition transition and related health challenges over decades in China
Lina Huang et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2021)
Pioneer of prostate cancer: past, present and the future ofFOXA1
Mona Teng et al.
PROTEIN & CELL (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Germline Pathogenic Variants in 7636 Japanese Patients With Prostate Cancer and 12 366 Controls
Yukihide Momozawa et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates
MaryBeth B. Culp et al.
EUROPEAN UROLOGY (2020)
Variation in Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy Outcomes in Asian American Men: A Multicenter Study
Michael D. Gross et al.
JOURNAL OF UROLOGY (2020)
Commercial Gene Expression Tests for Prostate Cancer Prognosis Provide Paradoxical Estimates of Race-Specific Risk
Jordan H. Creed et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)
Clinical and pathologic characteristics of familial prostate cancer in Asian population
Myong Kim et al.
PROSTATE (2020)
Measures of body fatness and height in early and mid-to-late adulthood and prostate cancer: risk and mortality in The Pooling Project of Prospective Studies of Diet and Cancer
J. M. Genkinger et al.
ANNALS OF ONCOLOGY (2020)
Shaping Chromatin States in Prostate Cancer by Pioneer Transcription Factors
William Hankey et al.
CANCER RESEARCH (2020)
Biomarker analysis of the phase III IPATential150 trial of first-line ipatasertib (Ipat) plus abiraterone (Abi) in metastatic castration-resistant prostate cancer (mCRPC).
Zhen Shi et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study
Peter Strom et al.
LANCET ONCOLOGY (2020)
Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study
Wouter Bulten et al.
LANCET ONCOLOGY (2020)
Genomic landscape of lung adenocarcinoma in East Asians
Jianbin Chen et al.
NATURE GENETICS (2020)
HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer
Jason W. D. Hearn et al.
JAMA ONCOLOGY (2020)
The Four-Kallikrein Panel Is Effective in Identifying Aggressive Prostate Cancer in a Multiethnic Population
Burcu F. Darst et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)
Personalized strategies in population screening for prostate cancer
Sebastiaan Remmers et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
A genomic and epigenomic atlas of prostate cancer in Asian populations
Jing Li et al.
NATURE (2020)
The diverse roles of SPOP in prostate cancer and kidney cancer
Zhiwei Wang et al.
NATURE REVIEWS UROLOGY (2020)
Olaparib for Metastatic Castration-Resistant Prostate Cancer
J. de Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
MEIS-mediated suppression of human prostate cancer growth and metastasis through HOXB13-dependent regulation of proteoglycans
Calvin VanOpstall et al.
ELIFE (2020)
Health Care Utilization and Costs of Patients With Prostate Cancer in China Based on National Health Insurance Database From 2015 to 2017
Lin Bai et al.
FRONTIERS IN PHARMACOLOGY (2020)
Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019
Veda N. Giri et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Targetable gene fusions and aberrations in genitourinary oncology
Filippo Pederzoli et al.
NATURE REVIEWS UROLOGY (2020)
Racial Differences in Genomic Profiling of Prostate Cancer
Brandon A. Mahal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Comparison of a 22-gene genomic classifier (GC) with NCCN for risk stratification of Asian prostate cancers (PCa)
W. Wai Yee et al.
ANNALS OF ONCOLOGY (2020)
Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets
Amol Patel et al.
JCO GLOBAL ONCOLOGY (2020)
Management of patients with advanced prostate cancer in the Asia Pacific region: real-world' consideration of results from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017
Edmund Chiong et al.
BJU INTERNATIONAL (2019)
Comparison of ERG and SPINK1 expression among incidental and metastatic prostate cancer in Japanese men
Haruhisa Koide et al.
PROSTATE (2019)
The impact of genetic polymorphism on CYP19A1 in androgen-deprivation therapy among Japanese men
Masaki Shiota et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2019)
A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer
Jonas Hugosson et al.
EUROPEAN UROLOGY (2019)
Use of Active Surveillance or Watchful Waiting for Low-Risk Prostate Cancer and Management Trends Across Risk Groups in the United States, 2010-2015
Brandon A. Mahal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Clinical use of current polygenic risk scores may exacerbate health disparities
Alicia R. Martin et al.
NATURE GENETICS (2019)
The expression profile and heterogeneity analysis of ERG in 633 consecutive prostate cancers from a single center
Ling Nie et al.
PROSTATE (2019)
CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis (vol 35, pg 603, 2019)
Michael A. Augello et al.
CANCER CELL (2019)
Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019
Giorgio Gandaglia et al.
EUROPEAN UROLOGY (2019)
Prostate Cancer, Version 2.2019
James L. Mohler et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Abiraterone acetate plus prednisone in patients with newly Croatia& diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial
Karim Fizazi et al.
LANCET ONCOLOGY (2019)
The Role of HOX Transcription Factors in Cancer Predisposition and Progression
Bo Li et al.
CANCERS (2019)
Future of cancer incidence in Shanghai, China: Predicting the burden upon the ageing population
Zhenqiu Liu et al.
CANCER EPIDEMIOLOGY (2019)
Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients
H. J. Boyle et al.
EUROPEAN JOURNAL OF CANCER (2019)
Germline DNA Repair Gene Mutation Landscape in Chinese Prostate Cancer Patients
Yu Wei et al.
EUROPEAN UROLOGY (2019)
Axon Guidance Molecules Promote Perineural Invasion and Metastasis of Orthotopic Pancreatic Tumors in Mice
Noelle R. Jurcak et al.
GASTROENTEROLOGY (2019)
Reporting of race in genome and exome sequencing studies of cancer: a scoping review of the literature
Adrienne Nugent et al.
GENETICS IN MEDICINE (2019)
Screening for prostate cancer: History, evidence, controversies and future perspectives toward individualized screening
Kazuto Ito et al.
INTERNATIONAL JOURNAL OF UROLOGY (2019)
Genetic analyses of diverse populations improves discovery for complex traits
Genevieve L. Wojcik et al.
NATURE (2019)
FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes
Elizabeth J. Adams et al.
NATURE (2019)
Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer
Abhijit Parolia et al.
NATURE (2019)
Genomics of disease risk in globally diverse populations
Deepti Gurdasani et al.
NATURE REVIEWS GENETICS (2019)
Molecular Underpinnings Governing Genetic Complexity of ETS-Fusion-Negative Prostate Cancer
Vipul Bhatia et al.
TRENDS IN MOLECULAR MEDICINE (2019)
Analysis of polygenic risk score usage and performance in diverse human populations
L. Duncan et al.
NATURE COMMUNICATIONS (2019)
Family history is significantly associated with prostate cancer and its early onset in Chinese population
Yang Xu et al.
PROSTATE (2019)
Global Variation in Opioid Use in Prostate Cancer Trials
Jessica K. Roydhouse et al.
JAMA ONCOLOGY (2019)
LBA8PROfound: Phase III study of olaparib versus enzalutamide or abiraterone for metastatic castration-resistant prostate cancer (mCRPC) with homologous recombination repair (HRR) gene alterations
S K Sandhu et al.
ANNALS OF ONCOLOGY (2019)
The prevalence and increasing trends of overweight, general obesity, and abdominal obesity among Chinese adults: a repeated cross-sectional study
Yongjie Chen et al.
BMC PUBLIC HEALTH (2019)
Changes in clinical trials of cancer drugs in mainland China over the decade 2009-18: a systematic review
Ning Li et al.
LANCET ONCOLOGY (2019)
Towards precision oncology in advanced prostate cancer
Sheng-Yu Ku et al.
NATURE REVIEWS UROLOGY (2019)
A Multicentre Evaluation of the Role of the Prostate Health Index (PHI) in Regions with Differing Prevalence of Prostate Cancer: Adjustment of PHI Reference Ranges is Needed for European and Asian Settings
Peter K-F Chiu et al.
EUROPEAN UROLOGY (2019)
A Prospective Study of the Association between Physical Activity and Risk of Prostate Cancer Defined by Clinical Features and TMPRSS2:ERG
Claire H. Pernar et al.
EUROPEAN UROLOGY (2019)
Homeobox B13 G84E Mutation and Prostate Cancer Risk
Tommy Nyberg et al.
EUROPEAN UROLOGY (2019)
PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer
Elena Castro et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancer
Dorhyun Johng et al.
PROSTATE (2019)
Classification of Cancer at Prostate MRI: Deep Learning versus Clinical PI-RADS Assessment
Patrick Schelb et al.
RADIOLOGY (2019)
Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade
Wassim Abida et al.
JAMA ONCOLOGY (2019)
The incidence, mortality, and risk factors of prostate cancer in Asian men
Byung Ha Chung et al.
PROSTATE INTERNATIONAL (2019)
Association of Missense Polymorphism in HSD3B1 With Outcomes Among Men With Prostate Cancer Treated With Androgen-Deprivation Therapy or Abiraterone
Masaki Shiota et al.
JAMA NETWORK OPEN (2019)
Post-GWAS in prostate cancer: from genetic association to biological contribution
Samaneh Farashi et al.
NATURE REVIEWS CANCER (2019)
Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide Prostate Cancers and their Relationship with the Human Development Index
Zaher Khazaei et al.
ADVANCES IN HUMAN BIOLOGY (2019)
Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk
Jennifer L. Caswell-Jin et al.
GENETICS IN MEDICINE (2018)
Ethnicity and ERG frequency in prostate cancer
Jason Sedarsky et al.
NATURE REVIEWS UROLOGY (2018)
ClinVar: improving access to variant interpretations and supporting evidence
Melissa J. Landrum et al.
NUCLEIC ACIDS RESEARCH (2018)
Preliminary efficacy and tolerability of chemohormonal therapy in metastatic hormone-naive prostate cancer: The first real-life experience in Asia
Darren M. C. Poon et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2018)
Dietary patterns and prostate cancer risk in Japanese: the Japan Public Health Center-based Prospective Study (JPHC Study)
Sangah Shin et al.
CANCER CAUSES & CONTROL (2018)
Smoking and Prostate Cancer-Specific Mortality after Diagnosis in a Large Prospective Cohort
Ted Gansler et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2018)
A Review of Prostate Cancer Genome-Wide Association Studies (GWAS)
Sarah Benafif et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2018)
Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression
Shancheng Ren et al.
EUROPEAN UROLOGY (2018)
Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging
Henrik Gronberg et al.
EUROPEAN UROLOGY (2018)
Cancer screening guidelines and policy making: 15 years of experience in cancer screening guideline development in Japan
Chisato Hamashima
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2018)
Prospective International Randomized Phase II Study of Low-Dose Abiraterone With Food Versus Standard Dose Abiraterone In Castration-Resistant Prostate Cancer
Russell Z. Szmulewitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial
Christos E. Kyriakopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016
Nancy Fullman et al.
LANCET (2018)
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
Claudia Allemani et al.
LANCET (2018)
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Fredrick R. Schumacher et al.
NATURE GENETICS (2018)
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13
Zhong Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
The Epidemiology of Prostate Cancer
Claire H. Pernar et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Association of HSD3B1 Genotype With Response to Androgen-Deprivation Therapy for Biochemical Recurrence After Radiotherapy for Localized Prostate Cancer
Jason W. D. Hearn et al.
JAMA ONCOLOGY (2018)
HSD3B1 and Response to a Nonsteroidal CYP17A1 Inhibitor in Castration-Resistant Prostate Cancer
Nima Almassi et al.
JAMA ONCOLOGY (2018)
Genetic structure, divergence and admixture of Han Chinese, Japanese and Korean populations
Yuchen Wang et al.
HEREDITAS (2018)
Are we inadvertently widening the disparity gap in pursuit of precision oncology?
Daniel E. Spratt
BRITISH JOURNAL OF CANCER (2018)
Genetics and biology of prostate cancer
Guocan Wang et al.
GENES & DEVELOPMENT (2018)
When will clinical trials finally reflect diversity?
Todd C. Knepper et al.
NATURE (2018)
Global Inequities in Precision Medicine and Molecular Cancer Research
Thomas M. Drake et al.
FRONTIERS IN ONCOLOGY (2018)
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
Christopher C. Parker et al.
LANCET (2018)
Urban-Rural Disparity in Cancer Incidence, Mortality, and Survivals in Shanghai, China, During 2002 and 2015
Xiaopan Li et al.
FRONTIERS IN ONCOLOGY (2018)
NCCN Asia Consensus Statement prostate cancer
Shiro Hinotsu et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2018)
Height, Obesity, and the Risk of TMPRSS2: ERG-Defined Prostate Cancer
Rebecca E. Graff et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2018)
Adaptation and external validation of the European randomised study of screening for prostate cancer risk calculator for the Chinese population
P. K. Chiu et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2017)
A Global Cancer Surveillance Framework Within Noncommunicable Disease Surveillance: Making the Case for Population-Based Cancer Registries
Marion Pineros et al.
EPIDEMIOLOGIC REVIEWS (2017)
Genetic Alterations in Esophageal Tissues From Squamous Dysplasia to Carcinoma
Xi Liu et al.
GASTROENTEROLOGY (2017)
Evidenced-based clinical practice guideline for prostate cancer (summary: Japanese Urological Association, 2016 edition)
Yoshiyuki Kakehi et al.
INTERNATIONAL JOURNAL OF UROLOGY (2017)
When public health intervention is not successful: Cost sharing, crowd-out, and selection in Korea's National Cancer Screening Program
Hyuncheol Bryant Kim et al.
JOURNAL OF HEALTH ECONOMICS (2017)
PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort
Tamara L. Lotan et al.
ONCOTARGET (2017)
Androgen Signaling in Prostate Cancer
Charles Dai et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Independent Validation of Effect of HSD3B1 Genotype on Response to Androgen-Deprivation Therapy in Prostate Cancer
Neeraj Agarwal et al.
JAMA ONCOLOGY (2017)
HOXB13 mutations and binding partners in prostate development and cancer: Function, clinical significance, and future directions
Hannah Brechka et al.
GENES & DISEASES (2017)
Trends in risk classification and primary therapy of Japanese patients with prostate cancer in Nara urological research and treatment group (NURTG) - comparison between 2004-2006, 2007-2009, and 2010-2012
Nobumichi Tanaka et al.
BMC CANCER (2017)
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair
T. R. Shenoy et al.
ANNALS OF ONCOLOGY (2017)
Impact of ethnicity on the outcome of men with metastatic, hormone-sensitive prostate cancer
Brandon Bernard et al.
CANCER (2017)
Trans-Pacific variation in outcomes for men treated with primary androgen-deprivation therapy (ADT) for prostate cancer
Matthew R. Cooperberg et al.
BJU INTERNATIONAL (2016)
Race-specific genetic risk score is more accurate than nonrace-specific genetic risk score for predicting prostate cancer and high-grade diseases
Rong Na et al.
ASIAN JOURNAL OF ANDROLOGY (2016)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness
Vijayalakshmi Kari et al.
EMBO REPORTS (2016)
Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries
Martin C. S. Wong et al.
EUROPEAN UROLOGY (2016)
A global view on cancer incidence and national levels of the human development index
Miranda M. Fidler et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Association of SLCO2B1 Genotypes With Time to Progression and Overall Survival in Patients Receiving Androgen-Deprivation Therapy for Prostate Cancer
Xiaodong Wang et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Population Frequency of Germline BRCA1/2 Mutations
Kara N. Maxwell et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Time Trends in Histological Features of Latent Prostate Cancer in Japan
Takahiro Kimura et al.
JOURNAL OF UROLOGY (2016)
HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study
Jason W. D. Hearn et al.
LANCET ONCOLOGY (2016)
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
C. C. Pritchard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The Expression Profile and Prognostic Value of SPINK1 in Initially Diagnosed Bone Metastatic Prostate Cancer
Xiuyi Pan et al.
PROSTATE (2016)
The prognostic impact of serum testosterone during androgen-deprivation therapy in patients with metastatic prostate cancer and the SRD5A2 polymorphism
M. Shiota et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2016)
Association between germline homeobox B13 (HOXB13) G84E allele and prostate cancer susceptibility: a meta-analysis and trial sequential analysis
Jianzhong Zhang et al.
ONCOTARGET (2016)
Changing Patterns of Primary Treatment in Korean Men with Prostate Cancer Over 10 Years: A Nationwide Population Based Study
Jinsung Park et al.
CANCER RESEARCH AND TREATMENT (2016)
Racial/Ethnic Disparities in Genomic Sequencing
Daniel E. Spratt et al.
JAMA ONCOLOGY (2016)
Economic Analysis of Prostate-Specific Antigen Screening and Selective Treatment Strategies
Joshua A. Roth et al.
JAMA ONCOLOGY (2016)
Invited Commentary: Screening and the Elusive Etiology of Prostate Cancer
Montserrat Garcia-Closas et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2015)
Associations of Body Mass Index, Smoking, and Alcohol Consumption With Prostate Cancer Mortality in the Asia Cohort Consortium
Jay H. Fowke et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2015)
Integrative Clinical Genomics of Advanced Prostate Cancer
Dan Robinson et al.
CELL (2015)
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse et al.
CELL (2015)
SRD5A gene polymorphism in Japanese men predicts prognosis of metastatic prostate cancer with androgen-deprivation therapy
Masaki Shiota et al.
EUROPEAN JOURNAL OF CANCER (2015)
Better Survival After Curative Treatment for Screen-detected Prostate Cancer Compared with Clinical Diagnosis: A Real Effect or Lead-time Bias? Reply
Sigrid V. Carlsson et al.
EUROPEAN UROLOGY (2015)
Characterization of 1577 Primary Prostate Cancers Reveals Novel Biological and Clinicopathologic Insights into Molecular Subtypes
Scott A. Tomlins et al.
EUROPEAN UROLOGY (2015)
Current use of active surveillance for localized prostate cancer: A nationwide survey in Japan
Koji Mitsuzuka et al.
INTERNATIONAL JOURNAL OF UROLOGY (2015)
Urologic cancers in Korea
Kyo Chul Koo et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2015)
Development and Application of a Lifestyle Score for Prevention of Lethal Prostate Cancer
S. A. Kenfield et al.
JNCI-Journal of the National Cancer Institute (2015)
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
Claudia Allemani et al.
LANCET (2015)
The TMPRSS2:ERG Fusion and Response to Androgen Deprivation Therapy for Prostate Cancer
Rebecca E. Graff et al.
PROSTATE (2015)
Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer
Meilin Wang et al.
NATURE COMMUNICATIONS (2015)
A Large Multiethnic Genome-Wide Association Study of Prostate Cancer Identifies Novel Risk Variants and Substantial Ethnic Differences
Thomas J. Hoffmann et al.
CANCER DISCOVERY (2015)
Development and Application of a Lifestyle Score for Prevention of Lethal Prostate Cancer
S. A. Kenfield et al.
JNCI-Journal of the National Cancer Institute (2015)
Prostate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in Asia
Yasuhide Kitagawa et al.
ASIAN JOURNAL OF ANDROLOGY (2015)
Determinants of participation in prostate cancer screening: A simple analytical framework to account for healthy-user bias
Takahiro Tabuchi et al.
CANCER SCIENCE (2015)
Effectiveness and safety of cabazitaxel plus prednisolone chemotherapy for metastatic castration-resistant prostatic carcinoma: data on Korean patients obtained by the cabazitaxel compassionate-use program
Jae-Lyun Lee et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Evidence for Molecular Differences in Prostate Cancer between African American and Caucasian Men
Francesca Khani et al.
CLINICAL CANCER RESEARCH (2014)
Prostate Cancer Risk Profiles of Asian-American Men: Disentangling the Effects of Immigration Status and Race/Ethnicity
Daphne Y. Lichtensztajn et al.
JOURNAL OF UROLOGY (2014)
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
Fritz H. Schroder et al.
LANCET (2014)
The physical activity transition among adults in China: 1991-2011
S. W. Ng et al.
OBESITY REVIEWS (2014)
Serine protease inhibitor Kazal type 1 promotes epithelial-mesenchymal transition through EGFR signaling pathway in prostate cancer
Chunni Wang et al.
PROSTATE (2014)
Prostate cancer in Asia: A collaborative report
Rui Chen et al.
ASIAN JOURNAL OF UROLOGY (2014)
Molecular Markers in Key Steroidogenic Pathways, Circulating Steroid Levels, and Prostate Cancer Progression
Eric Levesque et al.
CLINICAL CANCER RESEARCH (2013)
Genomic Profiling Defines Subtypes of Prostate Cancer with the Potential for Therapeutic Stratification
Jamie R. Schoenborn et al.
CLINICAL CANCER RESEARCH (2013)
Genetic polymorphisms of CYP17A1 in steroidogenesis pathway are associated with risk of progression to castration-resistant prostate cancer in Japanese men receiving androgen deprivation therapy
Takeshi Yamada et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2013)
A novel Germline mutation in HOXB13 is associated with prostate cancer risk in Chinese men
Xiaoling Lin et al.
PROSTATE (2013)
Polymorphisms of the androgen transporting gene SLCO2B1 may influence the castration resistance of prostate cancer and the racial differences in response to androgen deprivation
N. Fujimoto et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2013)
Trends in mortality from cancers of the breast, colon, prostate, esophagus, and stomach in East Asia: role of nutrition transition
Jianjun Zhang et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2012)
Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese
Shusuke Akamatsu et al.
NATURE GENETICS (2012)
Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4
Jianfeng Xu et al.
NATURE GENETICS (2012)
BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients
Z. Kote-Jarai et al.
BRITISH JOURNAL OF CANCER (2011)
Expression of SLCO Transport Genes in Castration-Resistant Prostate Cancer and Impact of Genetic Variation in SLCO1B3 and SLCO2B1 on Prostate Cancer Outcomes
Jonathan L. Wright et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Oncological outcomes of the prostate cancer patients registered in 2004: Report from the Cancer Registration Committee of the JUA
Hiroyuki Fujimoto et al.
INTERNATIONAL JOURNAL OF UROLOGY (2011)
SLCO2B1 and SLCO1B3 May Determine Time to Progression for Patients Receiving Androgen Deprivation Therapy for Prostate Cancer
Ming Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis
Xueying Mao et al.
CANCER RESEARCH (2010)
Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010
Seiji Naito et al.
INTERNATIONAL JOURNAL OF UROLOGY (2010)
Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population
Ryo Takata et al.
NATURE GENETICS (2010)
Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context
Gerrit Draisma et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Japanese Urological Association guidelines on prostate-specific antigen-based screening for prostate cancer and the ongoing cluster cohort study in Japan
Kazuto Ito et al.
INTERNATIONAL JOURNAL OF UROLOGY (2008)
Inherited variation in the androgen pathway is associated with the efficacy of androgen-deprivation therapy in men with prostate cancer
Robert W. Ross et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Cancer survival in five continents: a worldwide population-based study (CONCORD)
Michel P. Coleman et al.
LANCET ONCOLOGY (2008)
Age specific and attributable risks of familial prostate carcinoma from the family-cancer database
K Hemminki et al.
CANCER (2002)
Share Paper
